12:00 AM
 | 
Jan 01, 2007
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oxygent perflubron: Phase II start

This quarter, ALLP will begin a French Phase II trial to prevent POI resulting from hypoxia during...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >